DK208287D0 - 4(5)-substituerede imidazolderivater og fremgangsmaade til fremstilling deraf - Google Patents

4(5)-substituerede imidazolderivater og fremgangsmaade til fremstilling deraf

Info

Publication number
DK208287D0
DK208287D0 DK208287A DK208287A DK208287D0 DK 208287 D0 DK208287 D0 DK 208287D0 DK 208287 A DK208287 A DK 208287A DK 208287 A DK208287 A DK 208287A DK 208287 D0 DK208287 D0 DK 208287D0
Authority
DK
Denmark
Prior art keywords
lower alkyl
alkyl
substituted
procedures
producing
Prior art date
Application number
DK208287A
Other languages
English (en)
Other versions
DK208287A (da
DK172422B1 (da
Inventor
Arja Leena Karjalainen
Arto Johannes Karjalainen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI862039A external-priority patent/FI862039A0/fi
Priority claimed from FI870462A external-priority patent/FI870462A0/fi
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK208287D0 publication Critical patent/DK208287D0/da
Publication of DK208287A publication Critical patent/DK208287A/da
Application granted granted Critical
Publication of DK172422B1 publication Critical patent/DK172422B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Resins (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Dental Preparations (AREA)
  • Golf Clubs (AREA)
DK198702082A 1986-05-15 1987-04-24 (5)-substituerede imidazolderivater og fremgangsmåde til fremstilling deraf samt andre 4(5)-substituerede imidazolderivater DK172422B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FI862039A FI862039A0 (fi) 1986-05-15 1986-05-15 Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
FI862039 1986-05-15
FI870462A FI870462A0 (fi) 1987-02-04 1987-02-04 Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
FI870462 1987-02-04

Publications (3)

Publication Number Publication Date
DK208287D0 true DK208287D0 (da) 1987-04-24
DK208287A DK208287A (da) 1987-11-16
DK172422B1 DK172422B1 (da) 1998-06-08

Family

ID=26157963

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198702082A DK172422B1 (da) 1986-05-15 1987-04-24 (5)-substituerede imidazolderivater og fremgangsmåde til fremstilling deraf samt andre 4(5)-substituerede imidazolderivater

Country Status (18)

Country Link
US (2) US4933359A (da)
EP (1) EP0247764B1 (da)
JP (1) JP2561272B2 (da)
KR (1) KR950002158B1 (da)
AT (1) ATE66211T1 (da)
AU (1) AU600725B2 (da)
CA (1) CA1299186C (da)
DE (1) DE3772104D1 (da)
DK (1) DK172422B1 (da)
ES (1) ES2037712T3 (da)
FI (1) FI81092C (da)
GR (1) GR3002928T3 (da)
HU (1) HU197314B (da)
IE (1) IE59609B1 (da)
IL (1) IL82541A (da)
NO (1) NO166940C (da)
NZ (1) NZ220306A (da)
PT (1) PT84881B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
WO2000042023A1 (en) * 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6388090B2 (en) * 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
AU2001258469B2 (en) 2000-05-08 2005-04-14 Orion Corporation New polycyclic indanylimidazoles with alpha2 adrenergic activity
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
CA2627158A1 (en) * 2005-08-30 2007-03-08 Queen's University At Kingston Potentiation of the therapeutic action of an opioid receptor agonist and/or inhibition or reversal of tolerance to an opioid receptoi agonists using an ultralow dose of an alpha-2receptor antagonist
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
WO2011009928A1 (en) * 2009-07-24 2011-01-27 Dsm Pharma Chemicals Regensburg Gmbh Indane derivatives for use as intermediates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
US4480118A (en) * 1981-01-13 1984-10-30 Sumitomo Chemical Company, Limited Carboxylic acid ester and an insecticidal and/or acaricidal composition containing the same
ATE19621T1 (de) * 1981-09-15 1986-05-15 Ici Plc Aminosubstituierte tetraline und verwandte homocyclische verbindungen.
US4661522A (en) * 1984-05-24 1987-04-28 Akzo N.V. Cycloalkane-indene-carboximidamide derivatives
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
AU600725B2 (en) 1990-08-23
IE871258L (en) 1987-11-15
US4933359A (en) 1990-06-12
FI81092B (fi) 1990-05-31
EP0247764B1 (en) 1991-08-14
ATE66211T1 (de) 1991-08-15
HU197314B (en) 1989-03-28
NO872004L (no) 1987-11-16
DE3772104D1 (de) 1991-09-19
NO872004D0 (no) 1987-05-14
FI871655A7 (fi) 1987-11-16
JPS62289566A (ja) 1987-12-16
PT84881A (en) 1987-06-01
ES2037712T3 (es) 1993-07-01
KR880009941A (ko) 1988-10-06
US5026868A (en) 1991-06-25
KR950002158B1 (ko) 1995-03-14
NO166940B (no) 1991-06-10
FI871655A0 (fi) 1987-04-15
AU7310287A (en) 1987-11-19
NZ220306A (en) 1990-02-26
HUT45234A (en) 1988-06-28
GR3002928T3 (en) 1993-01-25
CA1299186C (en) 1992-04-21
PT84881B (pt) 1990-02-08
FI81092C (fi) 1990-09-10
IE59609B1 (en) 1994-03-09
DK208287A (da) 1987-11-16
IL82541A (en) 1992-06-21
JP2561272B2 (ja) 1996-12-04
IL82541A0 (en) 1987-11-30
NO166940C (no) 1991-09-25
EP0247764A1 (en) 1987-12-02
DK172422B1 (da) 1998-06-08

Similar Documents

Publication Publication Date Title
DK208287A (da) 4(5)-substituerede imidazolderivater og fremgangsmaade til fremstilling deraf
CA1268770C (en) Preparation of imidazole derivatives
DE69224212D1 (de) Piperazinderivate als 5-ht1a antagonisten.
HUT53099A (en) Process for producing new tetrahydrobenzimidazole derivatives and pharmaceutical compositions comprising such compounds
ES2112870T3 (es) Derivados de acido glicirretico.
KR890017244A (ko) 6-페닐-3-(피페라지닐알킬)-2,4-(1h,3h)-피리미딘디온 유도체, 그의 제법 및 치료에의 이용
DK493485A (da) Piperazinylindanderivater, syreadditionssalte deraf og farmaceutiskekompositioner
AU567117B2 (en) Indene derivatives
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
ATE90348T1 (de) Pyrido(2,3-d>pyrimidin-derivate.
SU1395143A3 (ru) Способ получени производных 1,6-нафтиридина в виде рацематов или энантиомеров,или их кислотно-аддитивных солей
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
DE3883891D1 (de) Benzimidazol-Derivate und Verfahren zu deren Herstellung.
CA2192596A1 (en) 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety
ES2080891T3 (es) Preparacion de derivados de amina norbornil opticamente activos.
AU646611B2 (en) 4-{4- or 6-(trifluoromethyl-2-pyridinyl)}-1-piperazinyl- alkyl substituted lactams
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired